Chugai Pharmaceutical Statistics

Total Valuation

Chugai Pharmaceutical has a market cap or net worth of JPY 11.69 trillion. The enterprise value is 10.88 trillion.

Market Cap	11.69T
Enterprise Value	10.88T

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Chugai Pharmaceutical has 1.65 billion shares outstanding. The number of shares has increased by 0.01% in one year.

Shares Outstanding	1.65B
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	20.62%
Float	639.47M

Valuation Ratios

The trailing PE ratio is 32.93 and the forward PE ratio is 31.40. Chugai Pharmaceutical's PEG ratio is 5.23.

PE Ratio	32.93
Forward PE	31.40
PS Ratio	10.78
PB Ratio	6.67
P/FCF Ratio	43.71
PEG Ratio	5.23

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.99, with an EV/FCF ratio of 40.66.

EV / Earnings	30.63
EV / Sales	10.03
EV / EBITDA	20.99
EV / EBIT	22.36
EV / FCF	40.66

Financial Position

The company has a current ratio of 5.09

Current Ratio	5.09
Quick Ratio	4.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	40,538.25

Financial Efficiency

Return on equity (ROE) is 21.75% and return on invested capital (ROIC) is 18.62%.

Return on Equity (ROE)	21.75%
Return on Assets (ROA)	15.62%
Return on Capital (ROIC)	18.62%
Revenue Per Employee	142.63M
Profits Per Employee	46.69M
Employee Count	7,604
Asset Turnover	0.56
Inventory Turnover	1.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+56.19%
50-Day Moving Average	6,801.86
200-Day Moving Average	5,838.28
Relative Strength Index (RSI)	55.66
Average Volume (20 Days)	2,423,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chugai Pharmaceutical had revenue of JPY 1.08 trillion and earned 355.04 billion in profits. Earnings per share was 215.76.

Revenue	1.08T
Gross Profit	753.36B
Operating Income	486.46B
Pretax Income	488.86B
Net Income	355.04B
EBITDA	518.10B
EBIT	486.46B
Earnings Per Share (EPS)	215.76

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	815.66B
Total Debt	n/a
Net Cash	815.66B
Net Cash Per Share	495.70
Equity (Book Value)	1.75T
Book Value Per Share	1,064.55
Working Capital	1.19T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 327.07 billion and capital expenditures -59.59 billion, giving a free cash flow of 267.48 billion.

Operating Cash Flow	327.07B
Capital Expenditures	-59.59B
Free Cash Flow	267.48B
FCF Per Share	162.56

Full Cash Flow Statement

Margins

Gross margin is 69.46%, with operating and profit margins of 44.85% and 32.74%.

Gross Margin	69.46%
Operating Margin	44.85%
Pretax Margin	45.07%
Profit Margin	32.74%
EBITDA Margin	47.77%
EBIT Margin	44.85%
FCF Margin	24.66%

Dividends & Yields

This stock pays an annual dividend of 82.00, which amounts to a dividend yield of 1.18%.

Dividend Per Share	82.00
Dividend Yield	1.18%
Dividend Growth (YoY)	1.25%
Years of Dividend Growth	2
Payout Ratio	36.97%
Buyback Yield	-0.01%
Shareholder Yield	1.17%
Earnings Yield	3.04%
FCF Yield	2.29%

Dividend Details

Stock Splits

The last stock split was on June 29, 2020. It was a forward split with a ratio of 3.

Last Split Date	Jun 29, 2020
Split Type	Forward
Split Ratio	3

Scores

Chugai Pharmaceutical has an Altman Z-Score of 19.05.

Altman Z-Score	19.05
Piotroski F-Score	n/a